CLARK ESTATES INC/NY - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
CLARK ESTATES INC/NY ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$14,147,000
-0.1%
325,0000.0%2.45%
+9.6%
Q1 2022$14,157,000
-28.7%
325,000
-27.8%
2.23%
-23.1%
Q4 2021$19,845,000
-2.9%
450,000
-15.9%
2.90%
-0.5%
Q3 2021$20,442,000
-4.0%
535,0000.0%2.92%
+4.9%
Q2 2021$21,304,000
+11.6%
535,0000.0%2.78%
+14.1%
Q1 2021$19,094,000
+7.0%
535,000
+10.3%
2.44%
-3.1%
Q4 2020$17,848,000
+41.5%
485,000
+44.8%
2.52%
+22.1%
Q3 2020$12,609,000
+31.5%
335,000
+42.6%
2.06%
+23.0%
Q2 2020$9,586,000
+7.7%
235,0000.0%1.68%
-7.5%
Q1 2020$8,904,000
+122.9%
235,000
+176.5%
1.81%
+196.6%
Q4 2019$3,994,000
-60.2%
85,000
-63.8%
0.61%
-63.0%
Q3 2019$10,030,000
+6.6%
235,0000.0%1.65%
+9.9%
Q2 2019$9,405,000
-4.2%
235,0000.0%1.50%
-1.1%
Q1 2019$9,821,000
-19.7%
235,000
-26.6%
1.52%
-22.4%
Q4 2018$12,227,000
-23.9%
320,000
-20.0%
1.96%
-18.7%
Q3 2018$16,068,000
-11.4%
400,000
-11.1%
2.41%
-11.0%
Q2 2018$18,140,000
-22.6%
450,000
-25.0%
2.71%
-27.7%
Q1 2018$23,442,000
+1.7%
600,000
-7.7%
3.75%
-1.6%
Q4 2017$23,056,000
+114.3%
650,000
+145.3%
3.81%
+113.2%
Q3 2017$10,759,000
+240.3%
265,000
+253.3%
1.79%
+266.7%
Q1 2017$3,162,00075,0000.49%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2022
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders